Competitive intelligence, clinical pipeline prioritization and development, market analysis. Area of focus was development of biologic therapeutics for malignant pleural effusion, malignant ascites, and peritoneal carcinomatosis in China and US markets

Strategy consulting with an emphasis on health care and life sciences. Projects include data-driven growth opportunity assessment and prioritization, competitive and operational bench-marking for providers / payers against industry standards and state / national guidelines, and commercial / vendor due diligence assessment on targets for private equity firms

Directed Evolution of a Myc transcription factor inhibitor through Yeast Display

Conducted network-wide branch and distribution analysis for a large regional bank that was used to re-align institutional resources with new customer behaviors Collaborated with colleagues to develop a de-novo pricing tool to be used in the commercial loans market by retail banks